Aleksandre Sambelashvili,Thomas J. Mullen,Todd J. Sheldon
申请号：
US16656981
公开号：
US20200046984A1
申请日:
2019.10.18
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Cardiac resynchronization therapy (CRT) delivered to a heart of a patient may be adjusted based on detection of a surrogate indication of the intrinsic atrioventricular conduction of the heart. In some examples, the surrogate indication is determined to be a sense event of the first depolarizing ventricle of the heart within a predetermined period of time following the delivery of a fusion pacing stimulus to the later depolarizing ventricle. In some examples, the CRT is switched from a fusion pacing configuration to a biventricular pacing configuration if the surrogate indication is not detected, and the CRT is maintained in a fusion pacing configuration if the surrogate indication is detected.
